Document is current
Any future updates will be listed below
-
Authors
Morrow, Matthew P. https://orcid.org/0009-0008-4176-1232
Gillespie, Elisabeth
Sylvester, Albert
Amin, Milan R.
Belafsky, Peter C.
Best, Simon R.
Friedman, Aaron D.
Klein, Adam M.
Lott, David G. https://orcid.org/0000-0001-6541-9687
Mau, Ted
Paniello, Randal C.
Pransky, Seth M. https://orcid.org/0009-0007-5397-1598
Saba, Nabil F. https://orcid.org/0000-0003-4972-1477
Tan, Grace S.
Wisotsky, Sadie
Marcus, Sarah A. https://orcid.org/0000-0002-3795-0806
Reuschel, Emma L. https://orcid.org/0000-0002-4627-1354
Reed, Katherine S.
Weiner, David B.
Dallas, Michael
Skolnik, Jeffrey M.
-
Funding
Funding for this research was provided by:
Inovio Pharmaceuticals
- License Information
-
More Information
Article History
Received: 1 August 2024
Accepted: 29 January 2025
First Online: 12 February 2025
Competing interests
: M.P.M., E.G., A.S., G.S.T., S.W., S.A.M., E.L.R., K.S.R., M.D., and J.M.S. are employees of and may hold stock and/or stock options in Inovio Pharmaceuticals. T.M., P.C.B., S.R.B., and D.G.L. received honoraria for consultancy for Inovio Pharmaceuticals. M.R.A. and R.C.P. have no funding, financial relationships, or conflicts of interest to disclose. A.D.F. received honoraria for consultancy for Inovio Pharmaceuticals and Precigen, Inc. A.M.K. receives support from the RRP Foundation for attending an RRPF Research meeting. S.M.P. receives honoraria for consultancy and advice for Inovio Pharmaceuticals; and is a member of the Recurrent Respiratory Task Force of the American Society of Pediatric Otolaryngology. N.F.S. provides advice for Inovio Pharmaceuticals; and provided compensated or non-compensated advisory role for Astra Zeneca, Merck, CUE Biopharma, and PDS. D.B.W. received remuneration as a member of the Board of Directors and consultant for Inovio Pharmaceuticals, and received honoraria for consultancy for Geneos, Flagship, and Advaccine, and as an advisor for Geneos, Astra Zeneca, BBI/Sumitomo, and Pfizer, and as a speaker for Astra Zeneca. All authors declare to have competing interests. None of the other authors have any competing interests.
